Haleon PLC Change to HY 2022 results date (3244Z)
13 Settembre 2022 - 5:07PM
UK Regulatory
TIDMHLN
RNS Number : 3244Z
Haleon PLC
13 September 2022
13 September 2022
Haleon plc
Change of Haleon HY 2022 results date
We were deeply saddened by the passing of Her Majesty Queen
Elizabeth II and join the people of the UK, the Commonwealth and
world in mourning her passing and offer our heartfelt condolences
to the Royal Family.
Respectful of the news that the State Funeral is taking place on
Monday 19th September 2022 and the announcement that this will be a
UK bank holiday we have decided to move our HY 2022 results release
from Monday 19th September to Tuesday 20(th) September 2022.
The results release will be available on the investors section
of the Haleon website at 7am BST (8am CET) with a recorded
presentation available shortly after. An analyst and investor
Q&A call will subsequently take place at 11:30am. Dial in
details will be published on the website and shared in the HY
release. A replay of the Q&A call will also be available on the
website shortly after the event.
ENDS
About Haleon
Haleon (LSE: HLN) is a global leader in consumer health, with
brands trusted by millions of consumers globally. The group employs
over 22,000 people across 170 markets, who are united by Haleon's
purpose - to deliver better everyday health with humanity. Haleon's
product portfolio spans five major categories - Oral Health, Pain
Relief, Respiratory Health, Digestive Health and Other, and
Vitamins, Minerals and Supplements (VMS). Its long-standing brands
- such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin,
Polident, parodontax and Centrum - are built on trusted science,
innovation and deep human understanding.
For more information, please visit www.haleon.com
Contact Details:
Investors: investor-relations@haleon.com
Media: corporate.media@haleon.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORUORVRUSUKAAR
(END) Dow Jones Newswires
September 13, 2022 11:07 ET (15:07 GMT)
Grafico Azioni Haleon (LSE:HLN)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Haleon (LSE:HLN)
Storico
Da Apr 2023 a Apr 2024